References
- Akslen LA, Sothern RB. (1998). Seasonal variations in the presentation and growth of thyroid cancer. Br J Cancer 77:1174–9
- Borisenkov MF. (2011). Latitude of residence and position in time zone are predictors of cancer incidence, cancer mortality, and life expectancy at birth. Chronobiol Int. 28:155–62
- Costa IC, Carvalho HN, Fernandes L. (2013). Aging, circadian rhythms and depressive disorders: A review. Am J Neurodegener Dis. 2:228–46
- Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009). New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–47
- Galea MH, Blamey RW. (1991). Season of initial detection in breast cancer. Br J Cancer. 63:157
- Gamelin EC, Danquechin-Dorval EM, Dumesnil YF, et al. (1996). Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer. 77:441–51
- Garland CF, Garland FC. (2006). Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 35:217–20
- Garufi C, Lévi F, Aschelter AM, et al. (1997). A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer. Eur J Cancer. 33:1566–71
- Halberg F. (1969). Chronobiology. Annu Rev Physiol. 31:675–725
- Heinemann V, von Weikersthal LF, Decker T, et al. (2014). FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastaticcolorectal cancer (FIRE-3): A randomised, open-label, phase 3 trial. Lancet Oncol. 15:1065–75
- Joensuu H, Toikkanen S. (1991). Association between the month of diagnosis and prognosis in breast carcinoma. Br J Cancer. 64:753–6
- Mason BH, Holdaway IM, Stewart AW, et al. (1990).Season of initial discovery of tumor as an independent variable predicting survival in breast cancer. Br J Cancer. 61:137–41
- Miller AB, Hoogstroten B, Staquet M, et al. (1981). Reporting results of cancer treatment. Cancer. 47:207–14
- Moan J, Lagunova Z, Bruland Ø, Juzeniene A. (2010). Seasonal variations of cancer incidence and prognosis. Dermatoendocrinol. 2:55–7
- Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, et al. (2011). Vitamin D status in patients with stage IV colorectal cancer: Findings from intergroup trial N9741. J Clin Oncol. 29:1599–606
- Pugliese P, Garufi C, Perrone M, et al. (2002). Quality of life and chronotherapy. Chronobiol Int. 19:299–312
- Robsahm TE, Tretli S, Dahlback A, Moan J. (2004). Vitamin D3 from sunlight may improve the prognosis of breast, colon and prostate cancer (Norway). Cancer Causes Control. 15:149–58
- Sankila R, Joensuu H, Pukkala E, Toikkanen S. (1993). Does the month of diagnosis affect survival of cancer patients? Br J Cancer. 67:838–41
- Smaaland R, Lote K, Sothern RB, Laerum OD. (1993). DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Cancer Res. 53:3129–38
- Steindal AH, Porojnicu AC, Moan J. (2007). Is the seasonal variation in cancer prognosis caused by sun-induced folate degradation? Med Hypotheses. 69:182–5
- Tournigand C, André T, Achille E, et al. (2004). FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol. 22:229–37
- Zgaga L, Theodoratou E, Farrington SM, et al. (2014). Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol. 32:2430–9